en

PRODUCT DETAIL

Icalziss 340 mmol/l infúzny roztok

Code 0608F
MA number 39/0248/25-S
Product Form: sol inf 20x500 ml (vak PP/PA/PE)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Vantive Belgium SRL, Belgium
Therapeutic Class: 39 - SOLI A IONTY PRO P.O. A PARENT. APLIKÁCIU
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
B05X I.V. SOLUTION ADDITIVES
B05XA Electrolyte solutions
B05XA07 Calcium chloride
Shelf life: 12
Container: bag PP/PA/PE
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10a well-established use application
MA issued: 19.08.2025
Validity: 19.08.2030
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric contraindication: Yes
Pediatric warnings: Yes
SPC: SPC_Icalziss 340 mmol/l infúzny roztok_sol inf_07/2025_REG.pdf  
PIL: PIL_Icalziss 340 mmol/l infúzny roztok_sol inf_07/2025_REG.pdf  
Safety feature No
Data update: 26.08.2025
eu-flag.png sk-flag.png